Albiger B, Dahlberg S, Sandgren A, Wartha F, Beiter K, Katsuragi H, Akira S, Normark S, Henriques-Normark B (2007) Toll-like receptor 9 acts at an early stage in host defence against pneumococcal infection. Cell Microbiol 9(3):633–644
Article CAS PubMed Google Scholar
Arafa MG, Girgis GNS, El-Dahan MS (2020) Chitosan-Coated PLGA nanoparticles for enhanced ocular anti-inflammatory efficacy of atorvastatin calcium. Int J Nanomed 15:1335–1347. https://doi.org/10.2147/IJN.S237314
Azim KF, Hasan M, Hossain MN (2019) Immunoinformatics approaches for designing a novel multi epitope peptide vaccine against human norovirus (Norwalk virus). Infect Genet Evol 74:103936. https://doi.org/10.1016/j.meegid.2019.103936
Article CAS PubMed Google Scholar
Behzadi P, García-Perdomo HA, Karpiński TM (2021) Toll-Like receptors: general molecular and structural biology. J Immunol Res 30:2021
Beiranvand S, Doosti A, Mirzaei SA (2021) Putative novel B-cell vaccine candidates identified by reverse vaccinology and genomics approaches to control Acinetobacter baumannii serotypes. Infect Genet Evol 15:105138
Bencze D, Fekete T, Pázmándi K (2021) Type I interferon production of plasmacytoid dendritic cells under control. Int J Mol Sci 22(8):4190
Article CAS PubMed PubMed Central Google Scholar
Benkő R, Gajdács M, Matuz M, Bodó G, Lázár A, Hajdú E, Papfalvi E, Hannauer P, Erdélyi P, Pető Z (2020) Prevalence and antibiotic resistance of ESKAPE pathogens isolated in the emergency department of a tertiary care teaching hospital in hungary: a 5-year retrospective survey. Antibiotics 9(9):624
Article PubMed PubMed Central Google Scholar
Bhan U, Lukacs NW, Osterholzer JJ, Newstead MW, Zeng X, Moore TA, McMillan TR, Krieg AM, Akira S, Standiford TJ (2007) TLR-9 is required for protective innate immunity in Gram-negative bacterial pneumonia: role of dendritic cells. J Immunol 179(6):3937–3946
Article CAS PubMed Google Scholar
Bhan U, Trujillo G, Lyn-Kew K, Newstead MW, Zeng X, Hogaboam CM, Krieg AM, Standiford TJ (2008) Toll-like receptor 9 regulates the lung macrophage phenotype and host immunity in murine pneumonia caused by Legionella pneumophila. Infect Immun 76(7):2895–2904
Article CAS PubMed PubMed Central Google Scholar
Bhan U, Ballinger MN, Zeng X, Newstead MJ, Cornicelli MD, Standiford TJ (2010) Cooperative interactions between TLR4 and TLR-9 regulate interleukin 23 and 17 production in a murine model of gram-negative bacterial pneumonia. PLoS ONE 5(3):e9896
Article PubMed PubMed Central Google Scholar
Bode C, Zhao G, Steinhagen F, Kinjo T, Klinman DM (2011) CpG DNA as a vaccine adjuvant. Expert Rev Vaccines 10(4):499–511. https://doi.org/10.1586/erv.10.174
Article CAS PubMed PubMed Central Google Scholar
Chuang YC, Cheng A, Sun HY (2019) Microbiological and clinical characteristics of Acinetobacter baumannii bacteremia: implications of sequence type for prognosis. J Infect 78(2):106–112. https://doi.org/10.1016/j.jinf.2018.10.0013
Doosti A, Pourabbas M, Arshi A, Chehelgerdi M, Kabiri H (2015) TEM and SHV genes in Klebsiella pneumoniae isolated from cockroaches and their antimicrobial resistance pattern. Osong Public Health Res Perspect 6(1):3–8
Du X, Xue J, Jiang M, Lin S, Huang Y, Deng K, Shu L, Xu H, Li Z, Yao J, Chen S (2021) A multiepitope peptide, rOmp22, encapsulated in chitosan-PLGA nanoparticles as a candidate vaccine against Acinetobacter baumannii infection. Int J Nanomed 16:1819
Duran V, Yasar H, Becker J (2019) Preferential uptake of chitosan-coated PLGA nanoparticles by primary human antigen presenting cells. Nanomedicine 21:102073. https://doi.org/10.1016/j.nano.2019.1020733
Article CAS PubMed Google Scholar
García-Patiño MG, García-Contreras R, Licona-Limón P (2017) The immune response against Acinetobacter baumannii, an emerging pathogen in nosocomial infections. Front Immunol 12(8):441
Ghorbani-Dalini S, Kargar M, Doosti A, Abbasi P, Sarshar M (2015) Molecular epidemiology of ESBLs genes and multi-drug resistance in diarrheagenic Escherichia Coli strains isolated from adults in Iran. Iran J Pharm Res 14(4):1257–1262
CAS PubMed PubMed Central Google Scholar
Goonewardene KB, Karu N, Ahmed KA (2021) CpG-ODN induced antimicrobial immunity in neonatal chicks involves a substantial shift in serum metabolic profiles. Sci Rep 11:9028. https://doi.org/10.1038/s41598-021-88386-2
Article CAS PubMed PubMed Central Google Scholar
Haas F, Yamauchi K, Murat M, Bernasconi M, Yamanaka N, Speck RF, Nadal D (2014) Activation of NF-κB via endosomal Toll-like receptor 7 (TLR7) or TLR9 suppresses murine herpesvirus 68 reactivation. J Virol 88(17):10002–10012
Article PubMed PubMed Central Google Scholar
Instruments M (2011) Zeta potential: an introduction in 30 minutes. Zetasizer Nano Serles Tech Note MRK654 1(2):1–6
Jia J, Zhang Y, Xin Y, Jiang C, Yan B, Zhai S (2018) Interactions between nanoparticles and dendritic cells: from the perspective of cancer immunotherapy. Front Oncol 8:404
Article PubMed PubMed Central Google Scholar
Judy BM, Taylor K, Deeraksa A, Johnston RK, Endsley JJ, Vijayakumar S, Aronson JF, Estes DM, Torres AG (2012) Prophylactic application of CpG oligonucleotides augments the early host response and confers protection in acute melioidosis. PLoS ONE 7(3):e34176
Article CAS PubMed PubMed Central Google Scholar
Keshavarzian N, Noroozbeygi M, Haji Molla Hoseini M, Yeganeh F (2020) Evaluation of leishmanization using iranian lizard leishmania mixed with CpG-ODN as a candidate vaccine against experimental murine leishmaniasis. Front Immunol 11:1725
Article CAS PubMed PubMed Central Google Scholar
Kim TH, Park J, Kim D, Gautam A, Akauliya M, Kim J, Lee H, Park S, Lee Y, Kwon HJ (2019) Anti-bacterial effect of CpG-DNA involves enhancement of the complement systems. Int J Mol Sci 20(14):3397
Article CAS PubMed PubMed Central Google Scholar
Klinmana DM, Barnhart KM, Conover J (1999) CpG motifs as immune adjuvants. Vaccine 17:19–25
Kojima Y, Xina K, Ookia T, Hamajimaa K, Oikawaa T, Shinodaa K, Ozakia T, Hoshinoa Y, Jounaia N, Nakazawab M, Klinmanc D, Okudaa K (2002) Adjuvant effect of multi- CpG motifs on an HIV-1 DNA vaccine. Vaccine 20:2857–2865
Article CAS PubMed Google Scholar
Krogmann AO, Lüsebrink E, Steinmetz M, Asdonk T, Lahrmann C, Lütjohann D, Nickenig G, Zimmer S (2016) Proinflammatory stimulation of toll-like receptor 9 with high dose CpG ODN 1826 impairs endothelial regeneration and promotes atherosclerosis in mice. PLoS ONE 11(1):e0146326
Article PubMed PubMed Central Google Scholar
Kuo TY, Lin MY, Coffman RL, Campbell JD, Traquina P, Lin YJ, Liu LT, Cheng J, Wu YC, Wu CC, Tang WH (2020) Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19. Sci Rep 10(1):1
Lai CY, Yu GY, Luo Y, Xiang R, Chuang TH (2019) Immunostimulatory activities of CpG-oligodeoxynucleotides in teleosts: toll-like receptors 9 and 21. Front Immunol 8(10):179
Li D, Wu M (2021) Pattern recognition receptors in health and diseases. Signal Transduct Target Ther 6(1):1–24
Liang X, Duan J, Li X (2018) Improved vaccine-induced immune responses via a ROS-triggered nanoparticle-based antigen delivery system. Nanoscale 10(20):9489–9503. https://doi.org/10.1039/C8NR00355F
Article CAS PubMed Google Scholar
Lin LCW, Huang CY, Yao BY (2019) Viromimetic STING agonistloaded hollow polymeric nanoparticles for safe and effective vaccination against Middle East respiratory syndrome coronavirus. Adv Funct Mater 29(28):1807616. https://doi.org/10.1002/adfm.201807616
Article CAS PubMed PubMed Central Google Scholar
Lin SY, Yao BY, Hu CM, Chen HW (2020) Induction of robust immune responses by CpG-ODN-loaded hollow polymeric nanoparticles for antiviral and vaccine applications in chickens. Int J Nanomed 15:3303
Makadia HK, Siegel SJ (2011) Poly Lactic-co-Glycolic Acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers 3:1377–1397. https://doi.org/10.3390/polym3031377
Article CAS PubMed Google Scholar
Martinson JA, Tenorio AR, Montoya CJ, Al-Harthi L, Gichinga CN, Krieg AM, Baum LL, Landay AL (2007) Impact of class A, B and C CpG-oligodeoxynucleotides on in vitro activation of innate immune cells in human immunodeficiency virus-1 infected individuals. Immunology 120(4):526–535
Article CAS PubMed PubMed Central Google Scholar
Mendez JM, Keestra-Gounder AM (2020) NF-κB-dependent luciferase activation and quantification of gene expression in salmonella infected tissue culture cells. JoVE (j vis Exp) 155:e60567
Morris FC, Dexter C, Kostoulias X, Uddin MI, Peleg AY (2019) The mechanisms of disease caused by Acinetobacter baumannii. Front Microbiol 17(10):1601
Mulani MS, Kamble EE, Kumkar SN, Tawre MS, Pardesi KR (2019a) Emerging strategies to combat ESKAPE pathogens in the era of antimicrobial resistance: a review. Front Microbiol 1(10):539
Mulani MS, Kamble EE, Kumkar SN, Tawre MS, Pardesi KR (2019b) Emerging strategies to combat ESKAPE pathogens in the er
留言 (0)